Comments
GlaxoSmithKline in deal with MD Anderson on cancer drugs
08.12.2012. | (Reuters) - GlaxoSmithKline signed a collaboration agreement with the MD Anderson Cancer Center in Houston to develop new drugs that promote a patient's immune system to attack cancer based on discoveries by Anderson researchers....
